We tested the hypothesis that cyclic changes in membrane potential (Em) underlie spontaneous vasomotion in cheek pouch arterioles of anesthetized hamsters. Diameter oscillations (∼3 min–1) were preceded (∼3 s) by oscillations in Em of smooth muscle cells (SMC) and endothelial cells (EC). Oscillations in Em were resolved into six phases: (1) a period (6 ± 2 s) at the most negative Em observed during vasomotion (–46 ± 2 mV) correlating (r = 0.87, p < 0.01) with time (8 ± 2 s) at the largest diameter observed during vasomotion (41 ± 2 µm); (2) a slow depolarization (1.8 ± 0.2 mV s–1) with no diameter change; (3) a fast (9.1 ± 0.8 mV s–1) depolarization (to –28 ± 2 mV) and constriction; (4) a transient partial repolarization (3–4 mV); (5) a sustained (5 ± 1 s) depolarization (–28 ± 2 mV) correlating (r = 0.78, p < 0.01) with time (3 ± 1 s) at the smallest diameter (27 ± 2 µm) during vasomotion; (6) a slow repolarization (2.5 ± 0.2 mV s–1) and relaxation. The absolute change in Em correlated (r = 0.60, p < 0.01) with the most negative Em. Sodium nitroprusside or nifedipine caused sustained hyperpolarization and dilation, whereas tetraethylammonium or elevated PO2 caused sustained depolarization and constriction. We suggest that vasomotion in vivo reflects spontaneous, cyclic changes in Em of SMC and EC corresponding with cation fluxes across plasma membranes.

1.
Colantuoni A, Bertuglia S, Intaglietta M: Quantitation of rhythmic diameter changes in arterial microcirculation. Am J Physiol 1984;246:H508–H517.
2.
Bouskela E, Grampp W: Spontaneous vasomotion in hamster cheek pouch arterioles in varying experimental conditions. Am J Physiol 1992;262:H478–H485.
3.
Fujii K, Heistad DD, Faraci FM: Ionic mechanisms in spontaneous vasomotion of the rat basilar artery in vivo. J Physiol 1990;430:389–398.
4.
Gustafsson H: Vasomotion and underlying mechanisms in small arteries. Acta Physiol Scand 1993;614:2–44.
5.
Verbeuren TJ, Vallez MO, Lavielle G, Bouskela E: Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation. Br J Pharmacol 1997;122:859–866.
6.
Intaglietta M: Arteriolar vasomotion: Implications for tissue ischemia. Blood Vessels 1991;28:1–7.
7.
Intaglietta M: Vasomotor activity, time-dependent fluid exchange and tissue pressure. Microvasc Res 1981;21:153–164.
8.
Griffith TM: Temporal chaos in the microcirculation. Cardiovasc Res 1996;31:342–358.
9.
Gokina NI, Bevan RD, Walters CL, Bevan JA: Electrical activity underlying rhythmic contraction in human pial arteries. Circ Res 1996;78:148–153.
10.
Hill CE, Eade J, Sandow SL: Mechanisms underlying spontaneous rhythmical contractions in irideal arterioles of the rat. J Physiol 1999;521:507–516.
11.
Folkow B: Description of the myogenic hypothesis. Circ Res 1964;15:279–287.
12.
Meyer JU, Lindbom L, Intaglietta M: Coordinated diameter oscillations at arteriolar bifurcations in skeletal muscle. Am J Physiol 1987;253:H568–H573.
13.
Sanders KM, Ward SM: Electrical rhythmicity in gastrointestinal muscles; in Bolton TB, Tomita T (eds): Smooth Muscle Excitation. San Diego, Academic Press, 1996, pp 417–426.
14.
Welsh DG, Segal SS: Endothelial and smooth muscle cell conduction in arterioles controlling blood flow. Am J Physiol 1998;274:H178–H186.
15.
Bartlett IS, Segal SS: Resolution of smooth muscle and endothelial pathways for conduction along hamster cheek pouch arterioles. Am J Physiol 2000;278:H604–H612.
16.
Ozaki H, Stevens RJ, Blondfield DP, Publicover NG, Sanders KM: Simultaneous measurement of membrane potential, cytosolic Ca2+, and tension in intact smooth muscles. Am J Physiol 1991;260:C917–C925.
17.
Nelson MT, Patlak JB, Worley JF, Standen NB: Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 1990;259:C3–C18.
18.
Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995;268:C799–C822.
19.
Pacaud P, Loirand G, Grégoire G, Mironneau C, Mironneau J: Calcium-dependence of the calcium-activated chloride current in smooth muscle cells of rat portal vein. Pflügers Arch 1992;421:125–130.
20.
Hirst GD, Edwards FR: Sympathetic neuroeffector transmission in arteries and arterioles. Physiol Rev 1989;69:546–604.
21.
Jackson WF: Ion channels and vascular tone. Hypertension 2000;35:173–178.
22.
Uyama Y, Imaizumi Y, Watanabe M: Effects of cyclopiazonic acid, a novel Ca(2+)-ATPase inhibitor, on contractile responses in skinned ileal smooth muscle. Br J Pharmacol 1992;106:208–214.
23.
Segal SS, Bény JL: Intracellular recording and dye transfer in arterioles during blood flow control. Am J Physiol 1992;263:H1–H7.
24.
Von der Weid PY, Bény JL: Simultaneous oscillations in the membrane potential of pig coronary artery endothelial and smooth muscle cells. J Physiol 1993;471:13–24.
25.
Little TL, Xia J, Duling BR: Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall. Circ Res 1995;76:498–504.
26.
Xia J, Little TL, Duling BR: Cellular pathways of the conducted electrical response in arterioles of hamster cheek pouch in vitro. Am J Physiol 1995;269:H2031–H2038.
27.
Welsh DG, Jackson WF, Segal SS: Oxygen induces electromechanical coupling in arteriolar smooth muscle cells: A role for L-type Ca2+ channels. Am J Physiol 1998;274:H2018–H2024.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.